Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
Authors
Keywords
HIV, Taiwan, HIV diagnosis and management, Antiretroviral therapy, Hepatitis C virus, HIV infections, Treatment guidelines, HIV epidemiology
Journal
PLoS One
Volume 12, Issue 6, Pages e0179870
Publisher
Public Library of Science (PLoS)
Online
2017-07-01
DOI
10.1371/journal.pone.0179870
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
- (2017) Pei-Ying Wu et al. PLoS One
- Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China
- (2016) SM Huang et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission
- (2016) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan
- (2016) Sui-Yuan Chang et al. Scientific Reports
- Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda
- (2015) Eugene Mutimura et al. AIDS
- Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States
- (2015) Jessie K. Edwards et al. CLINICAL INFECTIOUS DISEASES
- Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada
- (2015) L Lourenço et al. HIV MEDICINE
- Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan
- (2015) Chung-Chih Lai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia
- (2015) Stephen T Wright et al. Journal of the International AIDS Society
- The human immunodeficiency virus and ageing
- (2014) E. Bunting et al. AGE AND AGEING
- A Systematic Review and Meta-regression of Temporal Trends in Adult CD4+ Cell Count at Presentation to HIV Care, 1992-2011
- (2013) C. R. Lesko et al. CLINICAL INFECTIOUS DISEASES
- Hepatitis B Virus (HBV) Coinfection Accelerates Immunologic Progression in Patients With Primary HIV Infection in an Area of Hyperendemicity for HBV Infection
- (2013) Mao-Song Tsai et al. JOURNAL OF INFECTIOUS DISEASES
- Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan
- (2012) Chung-Chih Lai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Factors Associated with Late Antiretroviral Therapy Initiation among Adults in Mozambique
- (2012) Maria Lahuerta et al. PLoS One
- Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials
- (2011) J. A. Perez-Molina et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV transmission and high rates of late diagnoses among adults aged 50 years and over
- (2010) Ruth D Smith et al. AIDS
- Extremely High Prevalence and Genetic Diversity of Hepatitis C Virus Infection among HIV‐Infected Injection Drug Users in Taiwan
- (2008) Jyh‐You Liu et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started